Clinical Trials
Data from the first human study demonstrate excellent performance of Zerion Pharmas Dispersome technology
Zerion Pharma A/S announces positive results from the first human clinical study of a Dispersome® formulation of the drug Ivacaftor, a pharmaceutical used to treat cystic fibrosis. The study was conducted by ZERION’s Spanish partner Insud Pharma, a global...
News
Lab Operations Transitioning Towards The Digital Space
While making sure to get the kids ready for school, imagine a person of interest managing to steal a quick glance at her phone and discovering a notification informing her that one of the instruments in her lab was...
News
At Pharma Days in Geneva, TekniPlex Healthcare to Give Presentation on Blister Packaging Sustainability Per Rapidly Evolving EU Regulations
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will give a presentation highlighting multifaceted strategies toward making blister packages more sustainable at The Pharma Days, June 5-6 in Geneva. At June 5th at 2:20 p.m., Michiel van...
News
DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in...
News
Pharma and Regulatory Giants Tackle AI Trust and Legislative Challenges at Largest Ever Pistoia Alliance Annual Conference
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is calling for urgent collaboration to tackle growing challenges around AI regulation and use in life sciences. It comes following a survey, conducted...
News
The Future of Aesthetic Pharmacology Promising Trends and Innovations
For the past few years, drug development and the aesthetic medicine sphere have experienced significant growth, which is definitely a beneficial thing for pharmaceutical companies all around the world. The consequences are incredible: customer experience is boosted, people may...
News
Naprod Life Sciences successfully renews EU-GMP Certification for its Palghar facility
Naprod Life Sciences (Naprod) announced today the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar. The approval marks a significant milestone for Naprod in its journey of global leadership. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read